// Boldenone Undecylenate · EQ · 100:50 Ratio · Slow Aromatization · ~14 Day t½

EquipoiseBoldenone Undecylenate (EQ) — Research Reference by QSC Peptides

Equipoise (Boldenone Undecylenate / EQ) is the Δ1 analog of testosterone with a unique pharmacological profile: 100:50 anabolic:androgenic ratio, slow aromatization to estradiol (~50% of testosterone), and the longest half-life of common injectable AAS (~14 days) due to the undecylenate ester. QSC Peptides offers 300mg/mL — ≥99% purity, free USA shipping.

Compound Profile

BaseΔ1-testosterone (boldenone)
EsterUndecylenate (C11)
Anabolic:Androgenic100:50
Aromatization~50% of testosterone
Half-Life~14 days
ERB ActivityPossible
EPO StimulationDocumented
QSC Purity≥99%
QSC Peptides ≥99% Purity Verified COA Every Order Free USA USPS/FedEx US Domestic Stock 8 Warehouse Regions
// Mechanism of Action

How Equipoise Works

Equipoise (Boldenone Undecylenate) is the Δ1 analog of testosterone — a single additional double bond between C1 and C2 produces a compound with substantially different pharmacological properties despite structural similarity.

The Δ1 modification reduces 5α-reductase susceptibility (boldenone reduces to 5α-dihydroboldenone rather than DHT, with intermediate AR affinity) and reduces aromatization rate by ~50% vs testosterone — producing a gradual, lower-level estradiol increase. The 100:50 ratio indicates equivalent anabolic potency to testosterone with half the androgenic activity.

Undecylenate Ester — ~14 Day Half-Life

The undecylenate ester (C11, the longest common AAS ester) produces the slowest release pharmacokinetics of any common injectable AAS — ~14 day half-life, very slow Cmax, and prolonged AUC. This makes EQ uniquely suited for long-duration research models requiring extremely stable steroid levels with minimal injection frequency.

Erythropoietin (EPO) Stimulation

Boldenone has been associated with EPO stimulation and erythrocytosis in research — greater than testosterone at equivalent doses. This may involve direct renal effects distinct from the AR-mediated EPO pathway, making EQ a compound of interest in erythropoiesis research.

// Research Applications

Research Applications

  • Long-half-life pharmacokinetics: ~14 day t½ enables research protocols with maximal inter-sampling stability
  • Partial aromatization research: ~50% aromatization rate vs testosterone — studying intermediate estrogen levels
  • 5α-reduction comparison: Δ1 modification produces 5α-dihydroboldenone vs DHT from testosterone
  • EPO/erythropoiesis: Boldenone-associated EPO stimulation mechanisms distinct from standard androgen-EPO axis
  • Appetite stimulation: EQ documented to increase appetite in research models — relevant for weight gain studies
  • Veterinary pharmacology: Equipoise was developed as a veterinary compound — original research applications
// QSC Peptides Products

Buy Equipoise from QSC Peptides

Research-grade · ≥99% purity · COA · Free USA USPS/FedEx · US domestic warehouse

Equipoise
Equipoise 300mg/mL | 10-Vial Kit
Boldenone Undecylenate · EQ · ~14 day t½

QSC Peptides · 100:50 ratio

≥99% Pure · COA
// FAQ

Frequently Asked Questions

Equipoise is boldenone undecylenate — the Δ1 analog of testosterone with a C11 undecylenate ester. 100:50 anabolic:androgenic ratio, ~50% aromatization rate vs testosterone, ~14 day half-life. Associated with EPO stimulation and appetite increases in research. QSC Peptides offers 300mg/mL in 10-vial kits.
The undecylenate ester (C11 carbon chain) is the longest common AAS ester, producing the slowest depot release rate. This gives EQ approximately a 14-day half-life — the longest of any commonly used injectable AAS — making it suitable for research requiring very stable, slowly-declining steroid concentrations.
Yes. Free USPS/FedEx from US domestic warehouse on all orders.
// Related Compounds

Related AAS Research Compounds

Nandrolone
19-nor DECA/NPP
View reference →
Testosterone
Reference Compound
View reference →
Trenbolone
Most Potent 19-nor
View reference →
Masteron
DHT Injectable
View reference →

QSC Network